GENOPALATE, INC.

Profile

Company Names

GENOPALATE, INC.

Addresses

10437 W INNOVATION DR, STE 465, MILWAUKEE, WI 53226

10437 WEST INNOVATION DRIVE, #518, WAUWATOSA, WI 53226

470 S. ELMRIDGE AVENUE, BROOKFIELD, WI 53005

Phone Numbers

414-801-6686
4148016686

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$12,363,571.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2026-02-09 
$250,000.00 
$3,000,000.00 
$2,750,000.00 
Equity 
5
2022-10-07 
$6,047,456.00 
$11,086,498.00 
$5,039,042.00 
Equity 
4
2020-12-15 
$3,999,955.00 
$3,999,955.00 
$0.00 
Equity 
3
2019-12-02 
$1,000,000.00 
$3,000,000.00 
$2,000,000.00 
Debt 
2
2018-11-19 
$709,095.00 
$1,514,104.00 
$805,009.00 
Equity 
1
2018-03-19 
$357,065.00 
$357,065.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
T. 
BYRNES 
DIRECTOR, EXECUTIVE OFFICER
GENOPALATE, INC.
BRIAN 
 
GAGNE 
EXECUTIVE OFFICER
GENOPALATE, INC.   |  BRIDGE LOGISTICS US VENTURE II REIT LLC   |  BRIDGE LOGISTICS VALUE FUND II INTERNATIONAL LP   |  BRIDGE LOGISTICS VALUE FUND II INTERNATIONAL-R LP   |  BLV II REIT 2, LP   |  BLV II REIT, LLC   |  BRIDGE LOGISTICS VALUE FUND II INTERNATIONAL-A LP   |  BRIDGE LOGISTICS VALUE FUND II LP
DENNIS 
 
HODGES 
EXECUTIVE OFFICER
GENOPALATE, INC.
MICHAEL 
 
MCNALLY 
EXECUTIVE OFFICER
GENOPALATE, INC.
ASIF 
 
NASEEM 
EXECUTIVE OFFICER, DIRECTOR
GENOPALATE, INC.
CHAD 
 
RAUBE 
DIRECTOR
GENOPALATE, INC.
BRADLEY 
 
SIMMONS 
DIRECTOR
GENOPALATE, INC.
JOSEPH 
M. 
SMITH 
DIRECTOR
TENDYNE HOLDINGS, INC.   |  OCUDYNE, INC.   |  GENOPALATE, INC.
HARALD 
 
STELTZER 
DIRECTOR
ORISDX INC.   |  GENOPALATE, INC.
YI 
 
ZHANG 
DIRECTOR, EXECUTIVE OFFICER
RULAI, INC.   |  GENOPALATE, INC.   |  SCC DEV 2024B, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-09 
2022-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-07 
2020-12-29
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-15 
2019-12-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-02 
2018-12-03
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-19 
2018-05-03
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-03-19 
2018-03-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-03-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#